« Previous Entries

Seretide Accuhaler Drug Information

Monday, October 29th, 2018

Seretide Accuhaler is used for patients suffering from chronic obstructive pulmonary disease (COPD) or asthma. This medication helps patients control symptoms like wheezing and shortness of breath. Seretide Accuhaler is a powder form of fluticasone and salmeterol that comes with an inhaler device. This medication should not be used as a rescue inhaler in the […]

How Does Arcapta Neohaler Help Control COPD?

Tuesday, October 2nd, 2018

Chronic obstructive pulmonary disease (COPD) is a collective term used to describe a group of progressive lung diseases. It’s characterized by limited airflow from the lungs which can lead to the development of heart disease, cancer, and other major comorbidities. The most common forms of COPD are chronic bronchitis and emphysema. COPD is the fourth-leading […]

Tai Chi Could Help Treat COPD Patients

Monday, April 9th, 2018

In a new study, the researchers checked how effective tai chi, ancient Chinese martial art, is in treating COPD or chronic obstructive pulmonary disease. The researchers noted that it treats COPD just as effectively as pulmonary rehabilitation. COPD is used for referring a number of respiratory illnesses like chronic bronchitis, emphysema, and certain forms of […]

Household Disinfectants Linked to Increased Risk of Developing COPD

Monday, September 4th, 2017

Chronic Obstructive Pulmonary Disease or COPD is a term used for describing progressive lung diseases, including chronic bronchitis, refractory asthma, and emphysema. And according to latest research, common products used for cleaning a home might considerably increase the risk of COPD. It is estimated that approximately 15.7 million individuals in America are living with COPD. […]

Opioid Treatment Might Have Serious Side Effects in Older COPD Patients

Monday, July 18th, 2016

Older adults having COPD should think twice before taking opioids for the first time to relieve symptoms of their condition. This is the underlying message of a new study which found that adult COPD patients might carry an increased risk of respiratory problems as well as death if they take a new opioid prescription. COPD […]

Efficacy of COPD Medication Decrease on Exposure to Flu Virus and Cigarette Smoke

Saturday, April 9th, 2016

A new study supports the observations made by health experts that COPD symptom-reliever medication is less effective in flare-ups linked to influenza and cigarette smoking. The new research points towards a need to develop new drugs for treating COPD patients falling under these categories as well as a new model for testing new drugs. As […]

FDA approves new inhaled spray for COPD

Monday, October 19th, 2015

The US Food and Drug Administration (FDA) has approved olodaterol (brand name Striverdi Respimat) for treating chronic obstructive pulmonary disease (COPD). Striverdi Respimat is an inhaled spray and comes under the class of drugs known as long-acting beta-adrenergic agonists (LABAs). According to the FDA, the medicine works by keeping the airway muscles relaxed. It is […]

Exercise can help COPD patients overcome physical, work limitations

Tuesday, March 31st, 2015

New evidence from the US Centers for Disease Control and Prevention (CDC) suggests that with chronic obstructive pulmonary disease (COPD) patient reported physical limitations and trouble with working. However, the CDC also found that the rate of such issues was lower among COPD patients who were non-smokers and more physically active. The study was led […]

Healthy diet lowers COPD risk

Saturday, February 7th, 2015

A new study has indicated that a healthy diet could lower the risk of chronic obstructive pulmonary disease, or COPD.  This diet consists of more nuts and whole grains and less of sugar and red meat. The study was led by Raphaelle Varraso, PhD, of the University of Versailles in France. The researchrs wrote, “Although […]

FDA approves Striverdi Respimat for COPD

Friday, August 1st, 2014

A new chronic obstructive pulmonary disease (COPD) treatment medication has been approved by the US Food and Drug Administration (FDA). The medication in question is chronic obstructive pulmonary disease (COPD), and it has been approved to treat Boehringer Ingelheim’s COPD. The medication is part of a group of drugs called long-acting beta-adrenergic agonists (LABAs) that […]

« Previous Entries